Moderna, Inc. stock is up ~60% YTD on cancer vaccine trial data, 2026 readouts, and 2025 financials. Click for this updated look at MRNA stock prospects.
The U.S. Securities and Exchange Commission (SEC) is still pursuing accounting fraud. Despite the reduction in staffing in ...
Fourth quarter net income of $21.0 million ; Fourth quarter earnings per diluted common share of $0.70 ; Tax-equivalent net interest margin ...
Future income taxes are upcoming tax costs or savings due to discrepancies between financial statements and tax returns.
TUPELO, Miss., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Renasant Corporation (NYSE: RNST) (the “Company”) today announced earnings results for the fourth quarter of 2025.
Learn what operating netback is, how it's calculated, its role as a benchmark, and why it's critical for assessing profitability in the oil and gas industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results